Copeptin, resistant hypertension and renal sympathetic denervation

Biomarkers

Volumn 22, Issue 3-4, 2017, Pages 311-314

  Schwerg, Marius ^a   Slagman, Anna ^a   Stangl, Karl ^a   Stangl, Verena ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

antidiuretic hormone; Copeptin; Hypertension; renal denervation; vasopressin

Indexed keywords

COPEPTIN; BIOLOGICAL MARKER; GLYCOPEPTIDE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY DENERVATION; KIDNEY DENERVATION SYSTEM; MALE; MIDDLE AGED; RESISTANT HYPERTENSION; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TREATMENT RESPONSE; BLOOD; HYPERTENSION; INNERVATION; KIDNEY; PROGNOSIS; SYMPATHECTOMY;

AGED; BIOMARKERS; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; FOLLOW-UP STUDIES; GLYCOPEPTIDES; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; PROGNOSIS; SYMPATHECTOMY;

EID: 84994644840     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/1354750X.2016.1252968     Document Type: Article

References (25)

1. Acher, R., Chauvet, J., and Rouille, Y., 2002. Dynamic processing of neuropeptides:sequential conformation shaping of neurohypophysial preprohormones during intraneuronal secretory transport. Journal of Molecular Neuroscience, 18, 223–228.
2. Aoyagi, T., Koshimizu, T.A., and Tanoue, A., 2009. Vasopressin regulation of blood pressure and volume:findings from V1a receptor-deficient mice. Kidney International, 76, 1035–1039.
3. Berukstis, A., et al., 2016. Impact of renal sympathetic denervation on cardiac sympathetic nerve activity evaluated by cardiac MIBG imaging. EuroIntervention, 11, 1070–1076.
4. Bhatt, D.L., and Bakris, G.L., 2014. Renal denervation for resistant hypertension. New England Journal of Medicine, 371, 184.
5. Bonjour, J.P., and Malvin, R.L., 1970. Stimulation of ADH release by the renin-angiotensin system. American Journal of Physiology, 218, 1555–1559.
6. Coleman, C.G., Anrather, J., Iadecola, C., and Pickel, V.M., 2009. Angiotensin II type 2 receptors have a major somatodendritic distribution in vasopressin-containing neurons in the mouse hypothalamic paraventricular nucleus. Neuroscience, 163, 129–142.
7. De Bree, F.M., and Burbach, J.P., 1998. Structure-function relationships of the vasopressin prohormone domains. Cellular and Molecular Neurobiology, 18, 173–191.
8. Enhorning, S., et al., 2010. Plasma copeptin and the risk of diabetes mellitus. Circulation, 121, 2102–2108.
9. Grobe, J.L., Xu, D., and Sigmund, C.D., 2008. An intracellular renin-angiotensin system in neurons:fact, hypothesis, or fantasy. Physiology (Bethesda), 23, 187–193.
10. Head, G.A., and Mayorov, D.N., 2001. Central angiotensin and baroreceptor control of circulation. Annals of the New York Academy of Science, 940, 361–379.
11. Itaya, Y., et al., 1986. Central renin-angiotensin system and the pathogenesis of DOCA-salt hypertension in rats. American Journal of Physiology, 251, H261–H268.
12. Katan, M., et al. 2009. Copeptin:a novel, independent prognostic marker in patients with ischemic stroke. Annals of neurology, 66, 799–808.
13. Katan, M., et al., 2008. Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level. Neuro Endocrinology Letters, 29, 341–346.
14. Krum, H., et al., 2009. Catheter-based renal sympathetic denervation for resistant hypertension:a multicentre safety and proof-of-principle cohort study. Lancet, 373, 1275–1281.
15. Littlejohn, N.K., et al., 2013. Hypertension in mice with transgenic activation of the brain renin-angiotensin system is vasopressin dependent. American Journal of Physiology Regulatory Integrative Comparative Physiology, 304, R818–R828.
16. Mahfoud, F., et al., 2015. Proceedings from the European clinical consensus conference for renal denervation:considerations on future clinical trial design. European Heart Journal, 36, 2219–2227.
17. Mahfoud, F., et al., 2013. Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. European Heart Journal, 34, 2149–2157.
18. Morgenthaler, N.G., Struck, J., Alonso, C., and Bergmann, A., 2006. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clinical Chemistry, 52, 112–119.
19. Reichlin, T., et al., 2009. Incremental value of copeptin for rapid rule out of acute myocardial infarction. Journal of American College of Cardiology, 54, 60–68.
20. Schoen, T., et al., 2015. Plasma copeptin levels and ambulatory blood pressure characteristics in healthy adults. Journal of Hypertension, 33, 1571–1579.
21. Slagman, A., Searle, J., Muller, C., and Mockel, M., 2015. Temporal release pattern of copeptin and troponin T in patients with suspected acute coronary syndrome and spontaneous acute myocardial infarction. Clinical Chemistry, 61, 1273–1282.
22. Stewart, L.Q., et al., 2008. Pituitary-adrenal response to acute and repeated mild restraint, forced swim and change in environment stress in arginine vasopressin receptor 1b knockout mice. Journal of Neuroendocrinology, 20, 597–605.
23. Tenderenda-Banasiuk, E., et al., 2014. Serum copeptin levels in adolescents with primary hypertension. Pediatric Nephrology, 29, 423–429.
24. Uzun, F., et al., 2015. Serum copeptin levels in predicting nondippers in newly diagnosed hypertension. Blood Pressure Monitor, 20, 199–203.
25. Voors, A.A., et al., 2009. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction:results from the OPTIMAAL study. European Heart Journal, 30, 1187–1194.